TAKE CARE OF YOU AND YOUR PRACTICE DURING THIS PANDEMIC. WE ARE HERE TO HELP!

Blog

Study: COPD patients need more support when understanding new chest symptoms
February 19, 2019

Study: COPD patients need more support when understanding new chest symptoms

People with Chronic Obstructive Pulmonary Disease (COPD) need more support when understanding and acting on new chest symptoms, a study in the journal Psycho-Oncology reports. During this unique study, led by the University of Glasgow and University of Surrey, researchers investigated how the experience of COPD, influences how individuals understand new or changing chest symptoms and their…

Study: COPD patients need more support when understanding new chest symptoms
Study: E-cigarettes outperform patches and gums in quit-smoking study
February 05, 2019

Study: E-cigarettes outperform patches and gums in quit-smoking study

New study says e-cigarettes are twice as effective as nicotine gum and patches — the strongest evidence yet that vaping can help smokers quit cigarettes. A major new study provides the strongest evidence yet that vaping can help smokers quit cigarettes, with e-cigarettes proving nearly twice as effective as nicotine gums and patches. The British…

Study: E-cigarettes outperform patches and gums in quit-smoking study
Vaccination Cuts Risk of Severe Flu in Hospitalized Patients With COPD
January 21, 2019

Vaccination Cuts Risk of Severe Flu in Hospitalized Patients With COPD

Hospitalized patients with chronic obstructive pulmonary disease (COPD) who tested positive for the flu and were unvaccinated had worse death rates and more severe illness than those who were vaccinated, according to a recent study. A large national study from Canada showed influenza vaccination is effective in reducing flu-related hospitalizations among patients with chronic obstructive pulmonary…

Vaccination Cuts Risk of Severe Flu in Hospitalized Patients With COPD
Reducing drinking could help with smoking cessation, research finds
January 08, 2019

Reducing drinking could help with smoking cessation, research finds

If quitting smoking is one of you or your patient’s New Year’s resolutions, you might want to consider cutting back on your drinking, too. New research has found that heavy drinkers who are trying to stop smoking may find that reducing their alcohol use can also help them quit their daily smoking habit. Heavy drinkers’…

Reducing drinking could help with smoking cessation, research finds
December 18, 2018

Scientists found molecular ‘switch’ for allergic asthma treatment

A team of Russian scientists identified the role of the interleukin-6 molecule in the development of allergic asthma. Now it can be a new target for the treatment of this disease. The results are published in Frontiers in Immunology. About 300 million people worldwide suffer from asthma, one of the most common chronic lung diseases in…

December 04, 2018

This is why it’s so hard to quit smoking.

The science behind why it’s so difficult to quit smoking is crystal clear: Nicotine is addictive – reportedly as addictive as cocaine or heroin. Yet any adult can stroll into a drug store and buy a pack of cigarettes, no questions asked. “From a scientific standpoint, nicotine is just as hard, or harder, to quit…

October 30, 2018

Philip Morris stop-smoking campaign attacked as a PR stunt

Marlboro cigarette maker Philip Morris International (PM.N) drew accusations of hypocrisy after using a four-page newspaper advertisement to urge smokers to quit cigarettes. The wraparound advertisement covering Monday’s Daily Mirror tabloid is part of Philip Morris’s 2 million pound ($2.61 million) “Hold My Light” campaign, in which the world’s biggest international tobacco company is pushing…

October 16, 2018

Triple Therapy Improves COPD Exacerbations Regardless of Reversibility Status

Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI; Trelegy Ellipta) continues to boast positive findings from the Informing the Pathway of COPD Treatment (IMPACT) study. In new data to be presented at the 2018 CHEST Annual Meeting in San Antonio, TX, GlaxoSmithKline (GSK) has reported their first-of-its-kind triple therapy inhaler significantly reduced the annual rate of moderate-to-severe…